MEP37808A - Dna encoding a novel rg1 polypeptide - Google Patents

Dna encoding a novel rg1 polypeptide

Info

Publication number
MEP37808A
MEP37808A MEP-378/08A MEP37808A MEP37808A ME P37808 A MEP37808 A ME P37808A ME P37808 A MEP37808 A ME P37808A ME P37808 A MEP37808 A ME P37808A
Authority
ME
Montenegro
Prior art keywords
polypeptide
novel
polypeptides
dna encoding
methods
Prior art date
Application number
MEP-378/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Richard Harkins
Deborah Parkes
Gordon Parry
Douglas W Schneider
Renate Steinbrecher
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MEP37808A publication Critical patent/MEP37808A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
MEP-378/08A 1999-12-16 2000-12-15 Dna encoding a novel rg1 polypeptide MEP37808A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
PCT/US2000/033901 WO2001044291A2 (en) 1999-12-16 2000-12-15 Polynucleotid encoding the rg1 polypeptide

Publications (1)

Publication Number Publication Date
MEP37808A true MEP37808A (en) 2011-05-10

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-378/08A MEP37808A (en) 1999-12-16 2000-12-15 Dna encoding a novel rg1 polypeptide

Country Status (32)

Country Link
US (5) US6682902B2 (ko)
EP (2) EP1237915B1 (ko)
JP (1) JP4979867B2 (ko)
KR (1) KR100752434B1 (ko)
CN (1) CN1297566C (ko)
AT (1) ATE440862T1 (ko)
AU (1) AU784674B2 (ko)
BG (1) BG65898B1 (ko)
BR (1) BR0017022A (ko)
CA (1) CA2394574A1 (ko)
CZ (1) CZ299232B6 (ko)
DE (1) DE60042836D1 (ko)
DK (1) DK1237915T3 (ko)
EE (1) EE05293B1 (ko)
ES (1) ES2331106T3 (ko)
HR (1) HRP20020549B1 (ko)
HU (1) HU229001B1 (ko)
IL (2) IL150115A0 (ko)
LT (1) LT5046B (ko)
ME (1) MEP37808A (ko)
MX (1) MXPA02005914A (ko)
NO (1) NO330924B1 (ko)
NZ (1) NZ519598A (ko)
PL (1) PL207634B1 (ko)
PT (1) PT1237915E (ko)
RO (1) RO122543B1 (ko)
RS (1) RS50831B (ko)
RU (1) RU2283130C2 (ko)
SI (2) SI21140A (ko)
SK (2) SK288147B6 (ko)
WO (1) WO2001044291A2 (ko)
ZA (1) ZA200205638B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1251139A3 (en) * 1998-04-08 2002-12-18 Genentech, Inc. Human mindin-like protein and nucleic acids encoding it
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
NZ544911A (en) 2003-07-22 2008-12-24 Schering Ag RG1 antibodies and uses thereof
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI438207B (zh) * 2007-02-21 2014-05-21 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
EA201000921A1 (ru) * 2007-11-30 2010-12-30 Бристол-Маерс Сквибб Компани Конъюгаты антител против rg-1
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
EP0814159B1 (en) 1990-08-29 2005-07-27 GenPharm International, Inc. Transgenic mice capable of producing heterologous antibodies
AU687001B2 (en) 1992-05-14 1998-02-19 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting cancer development
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US6177244B1 (en) 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6287777B1 (en) * 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
WO1998008381A1 (en) * 1996-08-26 1998-03-05 University Of Washington Therapeutic and diagnostic applications of perlecan domain i splice variants
AU6961398A (en) 1997-04-10 1998-10-30 Zymogenetics Inc. Secreted f-spondin homologs
AU735444B2 (en) * 1997-05-06 2001-07-05 Human Genome Sciences, Inc. (Enterococcus faecalis) polynucleotides and polypeptides
WO1998050073A1 (en) 1997-05-09 1998-11-12 Smithkline Beecham Corporation Integrin ligand, human mindin
PT1490386E (pt) 1998-03-10 2008-11-24 Genentech Inc Novos polipéptidos e ácidos nucleicos que os codificam
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1126877A4 (en) 1998-10-19 2003-05-28 Diadexus Inc METHOD OF DIAGNOSIS, MONITORING, STADIUM CLASSIFICATION, VISUALIZATION AND TREATMENT OF PROSTATE CANCER
EE05627B1 (et) * 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Also Published As

Publication number Publication date
EP1237915B1 (en) 2009-08-26
US20090214422A1 (en) 2009-08-27
CN1297566C (zh) 2007-01-31
US7893217B2 (en) 2011-02-22
SI1237915T1 (sl) 2009-12-31
US7887804B2 (en) 2011-02-15
ATE440862T1 (de) 2009-09-15
LT2002070A (en) 2003-04-25
NO20022836L (no) 2002-08-15
SK288147B6 (sk) 2013-12-02
HUP0204224A3 (en) 2004-12-28
EE200200323A (et) 2003-10-15
ZA200205638B (en) 2003-10-15
HUP0204224A2 (hu) 2003-03-28
JP4979867B2 (ja) 2012-07-18
EE05293B1 (et) 2010-04-15
JP2003521244A (ja) 2003-07-15
BG65898B1 (bg) 2010-04-30
EP2048157A1 (en) 2009-04-15
DK1237915T3 (da) 2009-11-16
HRP20020549A2 (en) 2004-04-30
US7307154B2 (en) 2007-12-11
EP1237915A2 (en) 2002-09-11
SI21140A (sl) 2003-08-31
MXPA02005914A (es) 2003-02-27
LT5046B (lt) 2003-08-25
YU44602A (sh) 2005-06-10
US20090292112A1 (en) 2009-11-26
SK8482002A3 (en) 2003-02-04
RU2283130C2 (ru) 2006-09-10
AU784674B2 (en) 2006-05-25
WO2001044291A3 (en) 2002-01-17
NO330924B1 (no) 2011-08-22
NO20022836D0 (no) 2002-06-14
CN1434832A (zh) 2003-08-06
BG106823A (bg) 2003-04-30
US20040152139A1 (en) 2004-08-05
IL150115A (en) 2013-11-28
PL207634B1 (pl) 2011-01-31
NZ519598A (en) 2004-03-26
KR20020065575A (ko) 2002-08-13
SK286384B6 (sk) 2008-08-05
DE60042836D1 (de) 2009-10-08
RU2002119208A (ru) 2004-02-27
BR0017022A (pt) 2002-11-05
CA2394574A1 (en) 2001-06-21
CZ299232B6 (cs) 2008-05-21
KR100752434B1 (ko) 2007-08-27
PL356220A1 (en) 2004-06-28
ES2331106T3 (es) 2009-12-22
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
HU229001B1 (en) 2013-07-29
US20040023307A1 (en) 2004-02-05
EP2048157B1 (en) 2012-10-10
RO122543B1 (ro) 2009-08-28
HRP20020549B1 (hr) 2013-09-30
US20020004047A1 (en) 2002-01-10
IL150115A0 (en) 2002-12-01
AU3074601A (en) 2001-06-25
US6682902B2 (en) 2004-01-27
WO2001044291A2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
MEP37808A (en) Dna encoding a novel rg1 polypeptide
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
DK0991763T3 (da) Modificeret adenovirusfiber og måladenovirus
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
YU78194A (sh) Dna sastav protein kompleksa i postupak za dobijanje rekombinovanog protein kompleksa
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
NO932057L (no) Ny dopamin-menneske-reseptor og dens anvendelser
NO20011460L (no) Cytokinreseptor zalphall
DE69233463D1 (de) Expression und reinigung von kloniertem humanen alpha-fetoprotein
DE60039677D1 (de) Akt-3 nukleinsäure, polypeptide und deren verwendung
DK1290160T3 (da) Humane Pellino-polypeptider
DE60129688D1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
WO2003014293A3 (en) Novel polypeptide analogs and fusions and their methods of use
HUP0300813A2 (hu) Gének, fehérjék és alkalmazásuk
MY143222A (en) Expression vector for animal cell
AR242636A1 (es) Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos.
BR9810046A (pt) Sequência de nucleotìdeos, vetor de expressão, célula hospedeira, proteìna de esperma de mamìfero, proteìna de esperma recombinante, proteìna 4, 1 e/ou 6,7 de esperma, composição farmacêutica, e, vacina contraceptiva
PT1309690E (pt) Mfq-111, uma nova proteina do tipo gtpase humana